Skip to main content
SpringerLink
Log in

Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46(6):878–886

    Article  CAS  PubMed  Google Scholar 

  2. Ruprecht K, Klinker E, Dintelmann T, Rieckmann P, Gold R (2004) Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology 63(6):1081–1083

    CAS  PubMed  Google Scholar 

  3. Schilling S, Linker RA, Konig FB, Koziolek M, Bahr M, Muller GA, Paulus W, Gartner J, Bruck W, Chan A, Gold R (2006) Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients. Nervenarzt 77(4):430–438

    Article  CAS  PubMed  Google Scholar 

  4. Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366(9485):579–582

    Article  PubMed  Google Scholar 

  5. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58(1):143–146

    CAS  PubMed  Google Scholar 

  6. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):707–717

    Article  CAS  PubMed  Google Scholar 

  7. Pittock SJ, McClelland RL, Achenbach SJ, Konig F, Bitsch A, Bruck W, Lassmann H, Parisi JE, Scheithauer BW, Rodriguez M, Weinshenker BG, Lucchinetti CF (2005) Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry 76(12):1693–1697

    Article  CAS  PubMed  Google Scholar 

  8. The Canadian Cooperative Multiple Sclerosis Study Group (1991) The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. Lancet 337(8739):441–446

    Google Scholar 

  9. Khatri BO, McQuillen MP, Harrington GJ, Schmoll D, Hoffmann RG (1985) Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology 35(3):312–319

    CAS  PubMed  Google Scholar 

  10. Sorensen PS, Wanscher B, Szpirt W, Jensen CV, Ravnborg M, Christiansen P, Schreiber K, Nordenbo A (1996) Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study. Neurology 46(6):1620–1625

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Experimental and Clinical Neuroimmunology, Institute for MS research Medical Faculty, University of Göttingen and Gemeinnützige Hertie-Stiftung, 37073, Göttingen, Germany

    Ralf A. Linker MD, Andrew Chan MD & Ralf Gold MD

  2. Dept. of Clinical Neurophysiology, Medical Faculty, University of Göttingen, 37073, Göttingen, Germany

    Martin Sommer MD & Walter Paulus MD

  3. Dept. of Nephrology, Medical Faculty, University of Göttingen, 37073, Göttingen, Germany

    Michael Koziolek MD & Gerhard-Anton Müller MD

  4. Dept. of Neurology, St. Josef-Hospital/Ruhr-University, Gudrunstrassem 56, 44791, Bochum, Germany

    Ralf Gold MD

Authors
  1. Ralf A. Linker MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Chan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin Sommer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Koziolek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gerhard-Anton Müller MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Walter Paulus MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ralf Gold MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ralf Gold MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linker, R.A., Chan, A., Sommer, M. et al. Plasma exchange therapy for steroid-refractory superimposed relapses in secondary progressive multiple sclerosis. J Neurol 254, 1288–1289 (2007). https://doi.org/10.1007/s00415-006-0497-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0497-0

Keywords

Search

Navigation